Global Nuclear Medicine/Radiopharmaceuticals Competitive Landscape Professional Research Report 2024

Research Summary

Nuclear medicine is a medical specialty that combines the use of radioactive substances, known as radiopharmaceuticals, with imaging technology to diagnose and treat various diseases. Radiopharmaceuticals are specially designed drugs that contain a radioactive material, typically a radionuclide. These radionuclides emit gamma rays or positrons, which can be detected by specialized imaging equipment such as gamma cameras or PET scanners. In diagnostic nuclear medicine, patients are administered radiopharmaceuticals either orally, intravenously, or by inhalation. The radiopharmaceutical travels to specific organs or tissues based on their metabolic activity or specific affinity, allowing for the visualization and assessment of organ function, blood flow, or cellular activity. This imaging technique provides valuable information about the presence, location, and extent of diseases such as cancer, heart disease, brain disorders, and bone abnormalities. In therapeutic nuclear medicine, higher doses of radiopharmaceuticals are used for targeted radiation therapy to treat certain types of cancer by delivering radiation directly to tumor cells. Nuclear medicine and radiopharmaceuticals have revolutionized medical diagnosis and treatment by providing non-invasive, functional imaging and precise targeted therapies, leading to improved patient care and outcomes.

According to DIResearch's in-depth investigation and research, the global Nuclear Medicine/Radiopharmaceuticals market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Nuclear Medicine/Radiopharmaceuticals include China Isotope & Radiation, Dongcheng Pharmaceutical Group, Jaco, Ciaeriar, Advanced Molecular-imaging Solution, Shanghai Atom Kexing etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Nuclear Medicine/Radiopharmaceuticals. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nuclear Medicine/Radiopharmaceuticals market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nuclear Medicine/Radiopharmaceuticals market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nuclear Medicine/Radiopharmaceuticals industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nuclear Medicine/Radiopharmaceuticals Include:

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing

Nuclear Medicine/Radiopharmaceuticals Product Segment Include:

Diagnostic

Therapeutic

Nuclear Medicine/Radiopharmaceuticals Product Application Include:

Oncology

Thyroid

Cardiology

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Nuclear Medicine/Radiopharmaceuticals Industry PESTEL Analysis

Chapter 3: Global Nuclear Medicine/Radiopharmaceuticals Industry Porter's Five Forces Analysis

Chapter 4: Global Nuclear Medicine/Radiopharmaceuticals Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Nuclear Medicine/Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Nuclear Medicine/Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Nuclear Medicine/Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Nuclear Medicine/Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Nuclear Medicine/Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Nuclear Medicine/Radiopharmaceuticals Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Nuclear Medicine/Radiopharmaceuticals Market Overview

1.1 Product Definition and Statistical Scope

1.2 Nuclear Medicine/Radiopharmaceuticals Product by Type

1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Diagnostic

1.2.3 Therapeutic

1.3 Nuclear Medicine/Radiopharmaceuticals Product by Application

1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Others

1.4 Global Nuclear Medicine/Radiopharmaceuticals Market Revenue and Sales Analysis

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Analysis (2019-2030)

1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Sales Analysis (2019-2030)

1.4.3 Global Nuclear Medicine/Radiopharmaceuticals Market Sales Price Trend Analysis (2019-2030)

1.5 Nuclear Medicine/Radiopharmaceuticals Market Development Status and Trends

1.5.1 Nuclear Medicine/Radiopharmaceuticals Industry Development Status Analysis

1.5.2 Nuclear Medicine/Radiopharmaceuticals Industry Development Trends Analysis

2 Nuclear Medicine/Radiopharmaceuticals Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Nuclear Medicine/Radiopharmaceuticals Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis by Regions

4.1 Nuclear Medicine/Radiopharmaceuticals Overall Market: 2023 VS 2024 VS 2030

4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Region (2019-2024)

4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2025-2030)

4.3 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast Analysis (2019-2030)

4.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Region (2019-2024)

4.3.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Region (2025-2030)

4.4 Global Nuclear Medicine/Radiopharmaceuticals Sales Price Trend Analysis (2019-2030)

5 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type and Application

5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type

5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application

5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Type

6.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2030)

6.3.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2030)

6.4 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Application

6.4.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2030)

6.4.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2030)

6.5 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Type

7.3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2030)

7.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2030)

7.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Application

7.4.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2030)

7.4.2 ? Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2030)

7.5 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Nuclear Medicine/Radiopharmaceuticals Market Size by Type

8.3.1 China Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2030)

8.3.2 China Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2030)

8.4 China Nuclear Medicine/Radiopharmaceuticals Market Size by Application

8.4.1 China Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2030)

8.4.2 China Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Market Size by Type

9.3.1 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2030)

9.4 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Market Size by Application

9.4.1 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2030)

9.5 APAC (excl. China) Nuclear Medicine/Radiopharmaceuticals Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size by Type

10.3.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2030)

10.3.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2030)

10.4 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size by Application

10.4.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2030)

10.4.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2030)

10.5 Latin America Nuclear Medicine/Radiopharmaceuticals Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Type

11.3.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2019-2030)

11.3.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2019-2030)

11.4 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Application

11.4.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2019-2030)

11.4.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2019-2030)

11.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Nuclear Medicine/Radiopharmaceuticals Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Nuclear Medicine/Radiopharmaceuticals Average Sales Price by Manufacturers (2020-2024)

12.2 Nuclear Medicine/Radiopharmaceuticals Competitive Landscape Analysis and Market Dynamic

12.2.1 Nuclear Medicine/Radiopharmaceuticals Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 China Isotope & Radiation

13.1.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Portfolio

13.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Dongcheng Pharmaceutical Group

13.2.1 Dongcheng Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Dongcheng Pharmaceutical Group Nuclear Medicine/Radiopharmaceuticals Product Portfolio

13.2.3 Dongcheng Pharmaceutical Group Nuclear Medicine/Radiopharmaceuticals Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Jaco

13.3.1 Jaco Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Portfolio

13.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Ciaeriar

13.4.1 Ciaeriar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Portfolio

13.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Advanced Molecular-imaging Solution

13.5.1 Advanced Molecular-imaging Solution Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Portfolio

13.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Shanghai Atom Kexing

13.6.1 Shanghai Atom Kexing Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Portfolio

13.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Nuclear Medicine/Radiopharmaceuticals Industry Chain Analysis

14.2 Nuclear Medicine/Radiopharmaceuticals Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Nuclear Medicine/Radiopharmaceuticals Typical Downstream Customers

14.4 Nuclear Medicine/Radiopharmaceuticals Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support